|
|
 Previous Article | Table of Contents | Next Article 
flt3 Ligand in Cooperation With Transforming Growth Factor- 1 Potentiates In Vitro Development of Langerhans-Type Dendritic Cells and Allows Single-Cell Dendritic Cell Cluster Formation Under Serum-Free Conditions
Herbert Strobl,
Concha Bello-Fernandez,
Elisabeth Riedl,
Winfried F. Pickl,
Otto Majdic,
Stewart D. Lyman, and
Walter Knapp
From the Institute of Immunology-Vienna International Research Cooperation Center (VIRCC) at Sandoz Forschungsinstitut (SFI), and the Institute of Immunology, University of Vienna, Vienna, Austria; and Immunex Corp, Seattle, WA.
Using a recently described serum-free culture system of purified human CD34+ progenitor cells, we show here a critical cooperation of flt3 ligand (FL) with transforming growth factor- 1 (TGF-1) in the induction of in vitro dendritic cell/Langerhans cell (DC/LC) development. The addition of FL to serum-free cultures of CD34+ cells supplemented with TGF-1, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor  , and stem cell factor strongly increases both percentages (mean, 36% ± 5% v 64% ± 4%; P = .001) and total numbers (4.4- ± 0.8-fold) of CD1a+ dendritic cells. These in vitro-generated CD1a+ cells molecularly closely resemble a particular type of DC known as an epidermal Langerhans cell. Generation of DC under serum-free conditions was found to strictly require supplementation of culture medium with TGF-1. Upon omission of TGF-1, percentages of CD1a+ DC decreased (to mean, 10% ± 8%; P = .001) and, in turn, percentages of granulomonocytic cells (CD1a- cells that are lysozyme [LZ+]; myeloperoxidase [MPO+]; CD14+) increased approximately threefold (P < .05). Furthermore, in the absence of TGF-1, FL consistently promotes generation of LZ+, MPO+, and CD14+ cells, but not of CD1a+ cells. Serum-free single-cell cultures set up under identical TGF-1- and FL-supplemented culture conditions showed that high percentages of CD34+ cells (mean, 18% ± 2%; n = 4) give rise to day-10 DC colony formation. The majority of cells in these DC-containing colonies expressed the Langerhans cell/Birbeck granule specific marker molecule Lag. Without TGF-1 supplementation, Lag+ colony formation is minimal and formation of monocyte/macrophage-containing colonies predominates. Total cloning efficiency in the absence and presence of TGF-1 is virtually identical (mean, 41% ± 6% v 41% ± 4%). Thus, FL has the potential to strongly stimulate DC/LC generation, but has a strict requirement for TGF-1 to show this costimulatory effect.
Blood, Vol. 90 No. 4 (August 15), 1997:
pp. 1425-1434
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. M. Six, D. Bonhomme, M. Monteiro, K. Beldjord, M. Jurkowska, C. Cordier-Garcia, A. Garrigue, L. Dal Cortivo, B. Rocha, A. Fischer, et al.
A human postnatal lymphoid progenitor capable of circulating and seeding the thymus
J. Exp. Med.,
December 24, 2007;
204(13):
3085 - 3093.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Jorgl, B. Platzer, S. Taschner, L. X. Heinz, B. Hocher, P. M. Reisner, F. Gobel, and H. Strobl
Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB
Blood,
January 1, 2007;
109(1):
185 - 193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. Lee, L. Hertel, R. K. Louie, T. Burster, V. Lacaille, A. Pashine, D. A. Abate, E. S. Mocarski, and E. D. Mellins
Human Cytomegalovirus Alters Localization of MHC Class II and Dendrite Morphology in Mature Langerhans Cells
J. Immunol.,
September 15, 2006;
177(6):
3960 - 3971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Bechetoille, V. Andre, J. Valladeau, E. Perrier, and C. Dezutter-Dambuyant
Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli
J. Leukoc. Biol.,
July 1, 2006;
80(1):
45 - 58.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ito, Y. Minamiya, H. Kawai, S. Saito, H. Saito, T. Nakagawa, K. Imai, M. Hirokawa, and J.-i. Ogawa
Tumor-Derived TGFbeta-1 Induces Dendritic Cell Apoptosis in the Sentinel Lymph Node
J. Immunol.,
May 1, 2006;
176(9):
5637 - 5643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. C. Hornell, T. Burster, F. L. Jahnsen, A. Pashine, M. T. Ochoa, J. J. Harding, C. Macaubas, A. W. Lee, R. L. Modlin, and E. D. Mellins
Human Dendritic Cell Expression of HLA-DO Is Subset Specific and Regulated by Maturation
J. Immunol.,
March 15, 2006;
176(6):
3536 - 3547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. X. Heinz, B. Platzer, P. M. Reisner, A. Jorgl, S. Taschner, F. Gobel, and H. Strobl
Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment
Blood,
February 15, 2006;
107(4):
1445 - 1453.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Mende, H. Karsunky, I. L. Weissman, E. G. Engleman, and M. Merad
Flk2+ myeloid progenitors are the main source of Langerhans cells
Blood,
February 15, 2006;
107(4):
1383 - 1390.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Reeves, P. J. Lehner, J. G. P. Sissons, and J. H. Sinclair
An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling
J. Gen. Virol.,
November 1, 2005;
86(11):
2949 - 2954.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Menges, T. Baumeister, S. Rossner, P. Stoitzner, N. Romani, A. Gessner, and M. B. Lutz
IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity
J. Leukoc. Biol.,
April 1, 2005;
77(4):
535 - 543.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Reeves, P. A. MacAry, P. J. Lehner, J. G. P. Sissons, and J. H. Sinclair
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers
PNAS,
March 15, 2005;
102(11):
4140 - 4145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chang-Rodriguez, W. Hoetzenecker, C. Schwarzler, T. Biedermann, S. Saeland, and A. Elbe-Burger
Fetal and neonatal murine skin harbors Langerhans cell precursors
J. Leukoc. Biol.,
March 1, 2005;
77(3):
352 - 360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Lyakh, M. Sanford, S. Chekol, H. A. Young, and A. B. Roberts
TGF-{beta} and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells
J. Immunol.,
February 15, 2005;
174(4):
2061 - 2070.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Bella, S. Nicola, I. Timofeeva, M. L. Villa, A. Santoro, and A. C. Berardi
Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?
Blood,
December 15, 2004;
104(13):
4020 - 4028.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Platzer, A. Jorgl, S. Taschner, B. Hocher, and H. Strobl
RelB regulates human dendritic cell subset development by promoting monocyte intermediates
Blood,
December 1, 2004;
104(12):
3655 - 3663.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. O'Neill, S. Adams, and N. Bhardwaj
Manipulating dendritic cell biology for the active immunotherapy of cancer
Blood,
October 15, 2004;
104(8):
2235 - 2246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Encabo, P. Solves, E. Mateu, P. Sepulveda, F. Carbonell-Uberos, and M. D. Minana
Selective Generation of Different Dendritic Cell Precursors from CD34+ Cells by Interleukin-6 and Interleukin-3
Stem Cells,
September 1, 2004;
22(5):
725 - 740.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ratzinger, J. Baggers, M. A. de Cos, J. Yuan, T. Dao, J. L. Reagan, C. Munz, G. Heller, and J. W. Young
Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells
J. Immunol.,
August 15, 2004;
173(4):
2780 - 2791.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Chklovskaia, P. Nowbakht, C. Nissen, A. Gratwohl, M. Bargetzi, and A. Wodnar-Filipowicz
Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand
Blood,
May 15, 2004;
103(10):
3860 - 3868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Hertel, V. G. Lacaille, H. Strobl, E. D. Mellins, and E. S. Mocarski
Susceptibility of Immature and Mature Langerhans Cell-Type Dendritic Cells to Infection and Immunomodulation by Human Cytomegalovirus
J. Virol.,
July 1, 2003;
77(13):
7563 - 7574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Takahara, Y. Omatsu, Y. Yashima, Y. Maeda, S. Tanaka, T. Iyoda, B. Clusen, K. Matsubara, J. Letterio, R. M. Steinman, et al.
Identification and expression of mouse Langerin (CD207) in dendritic cells
Int. Immunol.,
May 1, 2002;
14(5):
433 - 444.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Iwama, M. Osawa, R. Hirasawa, N. Uchiyama, S. Kaneko, M. Onodera, K. Shibuya, A. Shibuya, C. Vinson, D. G. Tenen, et al.
Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment
J. Exp. Med.,
February 25, 2002;
195(5):
547 - 558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. F. Lipscomb and B. J. Masten
Dendritic Cells: Immune Regulators in Health and Disease
Physiol Rev,
January 1, 2002;
82(1):
97 - 130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. K. Affolter and P. F. Moore
Localized and Disseminated Histiocytic Sarcoma of Dendritic Cell Origin in Dogs
Vet. Pathol.,
January 1, 2002;
39(1):
74 - 83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bonkobara, P. K. Zukas, S. Shikano, S. Nakamura, P. D. Cruz Jr., and K. Ariizumi
Epidermal Langerhans Cell-Targeted Gene Expression by a Dectin-2 Promoter
J. Immunol.,
December 15, 2001;
167(12):
6893 - 6900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-C. Dieu-Nosjean, C. Massacrier, B. Vanbervliet, W.-H. Fridman, and C. Caux
IL-10 Induces CCR6 Expression During Langerhans Cell Development While IL-4 and IFN-{gamma} Suppress It
J. Immunol.,
November 15, 2001;
167(10):
5594 - 5602.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Soilleux and N. Coleman
Langerhans cells and the cells of Langerhans cell histiocytosis do not express DC-SIGN
Blood,
September 15, 2001;
98(6):
1987 - 1988.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Hayman, P. Macary, P. J. Lehner, and T. M. Cox
Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells
J. Histochem. Cytochem.,
June 1, 2001;
49(6):
675 - 684.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. Caron, Y. Delneste, E. Roelandts, C. Duez, N. Herbault, G. Magistrelli, J.-Y. Bonnefoy, J. Pestel, and P. Jeannin
Histamine Induces CD86 Expression and Chemokine Production by Human Immature Dendritic Cells
J. Immunol.,
May 15, 2001;
166(10):
6000 - 6006.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. MacAry, M. Lindsay, M. A. Scott, J. I. O. Craig, J. P. Luzio, and P. J. Lehner
Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells
PNAS,
March 27, 2001;
98(7):
3982 - 3987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Chklovskaia, C. Nissen, L. Landmann, C. Rahner, O. Pfister, and A. Wodnar-Filipowicz
Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor {gamma}-chain signaling and inhibited by cyclosporin A
Blood,
February 15, 2001;
97(4):
1027 - 1034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Riedl, J. Stockl, O. Majdic, C. Scheinecker, W. Knapp, and H. Strobl
Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation
Blood,
December 15, 2000;
96(13):
4276 - 4284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Gazitt
Immunologic Profiles of Effector Cells and Peripheral Blood Stem Cells Mobilized with Different Hematopoietic Growth Factors
Stem Cells,
November 1, 2000;
18(6):
390 - 398.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. J. Soilleux, R. Barten, and J. Trowsdale
Cutting Edge: DC-SIGN; a Related Gene, DC-SIGNR; and CD23 Form a Cluster on 19p13
J. Immunol.,
September 15, 2000;
165(6):
2937 - 2942.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld
Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis
Blood,
September 15, 2000;
96(6):
2022 - 2036.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-C. Dieu-Nosjean, C. Massacrier, B. Homey, B. Vanbervliet, J.-J. Pin, A. Vicari, S. Lebecque, C. Dezutter-Dambuyant, D. Schmitt, A. Zlotnik, et al.
Macrophage Inflammatory Protein 3{alpha} Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors
J. Exp. Med.,
September 5, 2000;
192(5):
705 - 718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Riedl, J. Stockl, O. Majdic, C. Scheinecker, K. Rappersberger, W. Knapp, and H. Strobl
Functional Involvement of E-Cadherin in TGF-{beta}1-Induced Cell Cluster Formation of In Vitro Developing Human Langerhans-Type Dendritic Cells
J. Immunol.,
August 1, 2000;
165(3):
1381 - 1386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Oh, J. M. McCaffery, and M. C. Eichelberger
Dose-Dependent Changes in Influenza Virus-Infected Dendritic Cells Result in Increased Allogeneic T-Cell Proliferation at Low, but Not High, Doses of Virus
J. Virol.,
June 15, 2000;
74(12):
5460 - 5469.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. J. McKenna, K. L. Stocking, R. E. Miller, K. Brasel, T. De Smedt, E. Maraskovsky, C. R. Maliszewski, D. H. Lynch, J. Smith, B. Pulendran, et al.
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
Blood,
June 1, 2000;
95(11):
3489 - 3497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Gatti, M. A. Velleca, B. C. Biedermann, W. Ma, J. Unternaehrer, M. W. Ebersold, R. Medzhitov, J. S. Pober, and I. Mellman
Large-Scale Culture and Selective Maturation of Human Langerhans Cells from Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Progenitors
J. Immunol.,
April 1, 2000;
164(7):
3600 - 3607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Brenner, C. Rossig, U. Sili, J. W. Young, and E. Goulmy
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy | |
